Anticoagulant Linked With Lower Risk of Death Following Heart Attack Compared to Heparin

Patients who experienced a certain type of heart attack who received the anticoagulant fondaparinux had a lower risk of major bleeding events and death both in the hospital and after six months compared to patients who received low-molecular-weight heparin (LMWH), although both groups had similar rates of subsequent heart attack or stroke, according to a new study.



from Today's Healthcare News -- ScienceDaily http://ift.tt/1Jo4Tw2